The Journal of Immunology, Vol 147, Issue 4 1445-1452, Copyright © 1991 by American Association of Immunologists

ARTICLES

Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation

F Novelli, M Giovarelli, R Reber-Liske, G Virgallita, G Garotta and G Forni
Institute of Microbiology, University of Turin, Italy.

The role of physiologically secreted human IFN-gamma in T lymphocyte and NK cell activation has been probed with a panel of mouse mAb directed against various epitopes of the human IFN-gamma molecule, or human IFN-gamma R. Addition to the culture medium of those mAb that neutralize the antiviral activity of IFN-gamma or interact with its receptor inhibited proliferative and cytotoxic responses elicited in PBL by HLA alloantigens, anti-CD3 mAb, and IL-2, but not the proliferative response to PHA. The IFN-gamma blockade also inhibited IFN-gamma, IL-2, and TNF-alpha release during MLC. Kinetic experiments showed that reduction of proliferative and cytotoxic responses to HLA alloantigens is maximal when IFN-gamma is blocked within the first 48 h. Exogenous rIFN-gamma restored the proliferative response only when added at the beginning. Moreover, when IFN-gamma was blocked, T lymphocytes recovered from 6-day MLC displayed a profound decrease in their expression of p55 and p75 chains of the IL-2R, as well as in the number of high-affinity IL-2 binding sites. These findings strongly suggest that IFN-gamma is required in the early phases of induction of the oligo- and polyclonal proliferative and cytotoxic responses of lymphocytes.

This article has been cited by other articles:

				S. Banerjee, A. Smallwood, J. Moorhead, A. E. Chambers, A. Papageorghiou, S. Campbell, and K. Nicolaides Placental Expression of Interferon-{gamma} (IFN-{gamma}) and Its Receptor IFN-{gamma}R2 Fail to Switch from Early Hypoxic to Late Normotensive Development in Preeclampsia J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 944 - 952. [Abstract] [Full Text] [PDF]

				B. Rose, C. Herder, H. Loffler, H. Kolb, and S. Martin Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents J. Leukoc. Biol., April 1, 2004; 75(4): 624 - 630. [Abstract] [Full Text] [PDF]

				A. B. Geldhof, J. A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation Blood, December 1, 2002; 100(12): 4049 - 4058. [Abstract] [Full Text] [PDF]

				P. Bernabei, E. M. Coccia, L. Rigamonti, M. Bosticardo, G. Forni, S. Pestka, C. D. Krause, A. Battistini, and F. Novelli Interferon-{gamma} receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death J. Leukoc. Biol., December 1, 2001; 70(6): 950 - 960. [Abstract] [Full Text] [PDF]

				L. Rigamonti, S. Ariotti, G. Losana, R. Gradini, M. A. Russo, E. Jouanguy, J.-L. Casanova, G. Forni, and F. Novelli Surface Expression of the IFN-{gamma}R2 Chain Is Regulated by Intracellular Trafficking in Human T Lymphocytes J. Immunol., January 1, 2000; 164(1): 201 - 207. [Abstract] [Full Text] [PDF]

				A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis J. Immunol., October 15, 1999; 163(8): 4182 - 4191. [Abstract] [Full Text] [PDF]

				A. Allione, V. Wells, G. Forni, L. Mallucci, and F. Novelli {beta}-Galactoside-Binding Protein ({beta}GBP) Alters the Cell Cycle, Up-Regulates Expression of the {alpha}- and {beta}-Chains of the IFN-{gamma} Receptor, and Triggers IFN-{gamma}-Mediated Apoptosis of Activated Human T Lymphocytes J. Immunol., September 1, 1998; 161(5): 2114 - 2119. [Abstract] [Full Text] [PDF]

				D. Zella, O. Barabitskaja, J. M. Burns, F. Romerio, D. E. Dunn, M. G. Revello, G. Gerna, M. S. R. Jr, R. C. Gallo, and F. F. Weichold Interferon-gamma Increases Expression of Chemokine Receptors CCR1, CCR3, and CCR5, But Not CXCR4 in Monocytoid U937 Cells Blood, June 15, 1998; 91(12): 4444 - 4450. [Abstract] [Full Text] [PDF]